- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Insider Buying
Global Pharmaceuticals & Biotech High Insider Buying
Results
197
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
197 companies
Bristol-Myers Squibb
Market Cap: US$95.1b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
US$46.75
7D
0.6%
1Y
6.2%
GSK
Market Cap: UK£56.6b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£13.95
7D
1.2%
1Y
-21.4%
CSL
Market Cap: AU$117.1b
Researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
CSL
AU$241.82
7D
1.0%
1Y
-13.6%
argenx
Market Cap: €30.8b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€504.40
7D
1.7%
1Y
48.4%
Illumina
Market Cap: US$13.2b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$83.62
7D
10.4%
1Y
-24.7%
Viatris
Market Cap: US$10.4b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$8.84
7D
0.8%
1Y
-19.5%
Moderna
Market Cap: US$9.6b
A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
MRNA
US$24.86
7D
2.5%
1Y
-81.3%
Avantor
Market Cap: US$9.1b
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
AVTR
US$13.41
7D
11.6%
1Y
-46.3%
Medpace Holdings
Market Cap: US$8.8b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$305.66
7D
3.3%
1Y
-22.3%
CSPC Pharmaceutical Group
Market Cap: HK$67.3b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$5.89
7D
2.6%
1Y
-11.0%
Repligen
Market Cap: US$7.1b
A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.
RGEN
US$126.50
7D
2.6%
1Y
-26.4%
Jazz Pharmaceuticals
Market Cap: US$6.7b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$108.98
7D
11.5%
1Y
-0.009%
Elanco Animal Health
Market Cap: US$6.4b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$12.92
7D
8.0%
1Y
-24.8%
Bruker
Market Cap: US$5.7b
Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.
BRKR
US$37.53
7D
0.03%
1Y
-50.0%
Ionis Pharmaceuticals
Market Cap: US$5.3b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$33.56
7D
4.0%
1Y
-10.1%
Regencell Bioscience Holdings
Market Cap: US$5.1b
Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
RGC
US$393.00
7D
7.4%
1Y
7,443.2%
Grand Pharmaceutical Group
Market Cap: HK$29.5b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$8.43
7D
12.9%
1Y
64.6%
Viking Therapeutics
Market Cap: US$3.2b
A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.
VKTX
US$28.43
7D
3.2%
1Y
-57.6%
Aspen Pharmacare Holdings
Market Cap: R54.2b
Manufactures and supplies specialty and branded pharmaceutical products worldwide.
APN
R122.01
7D
-2.3%
1Y
-46.9%
AddLife
Market Cap: SEK 23.1b
Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 189.40
7D
0.6%
1Y
64.4%
Organon
Market Cap: US$2.4b
Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.
OGN
US$9.04
7D
3.8%
1Y
-58.5%
Alembic Pharmaceuticals
Market Cap: ₹179.5b
Develops, manufactures, and markets pharmaceutical products in India and internationally.
APLLTD
₹912.95
7D
1.4%
1Y
-5.7%
Biohaven
Market Cap: US$1.6b
Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide.
BHVN
US$16.02
7D
-20.8%
1Y
-57.1%
Mesoblast
Market Cap: AU$2.2b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$1.73
7D
1.5%
1Y
59.4%
Indivior
Market Cap: UK£1.1b
Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
INDV
UK£8.45
7D
2.0%
1Y
-36.8%
Biotage
Market Cap: SEK 11.4b
Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.
BIOT
SEK 142.00
7D
0.2%
1Y
-20.7%
10x Genomics
Market Cap: US$1.2b
A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.
TXG
US$9.39
7D
7.1%
1Y
-62.5%
BioGaia
Market Cap: SEK 10.7b
A healthcare company, provides probiotic products worldwide.
BIOG B
SEK 105.70
7D
4.8%
1Y
-19.3%
SSY Group
Market Cap: HK$8.5b
An investment holding company, research, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.89
7D
-2.4%
1Y
-40.3%
Neuren Pharmaceuticals
Market Cap: AU$1.6b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$13.19
7D
-0.8%
1Y
-37.5%
Phibro Animal Health
Market Cap: US$972.8m
Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.
PAHC
US$24.00
7D
6.8%
1Y
30.4%
Ardelyx
Market Cap: US$928.3m
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$3.88
7D
7.2%
1Y
-50.3%
Arcus Biosciences
Market Cap: US$906.4m
A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.
RCUS
US$8.56
7D
3.4%
1Y
-49.3%
Niagen Bioscience
Market Cap: US$864.4m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$10.95
7D
22.3%
1Y
231.8%
Geron
Market Cap: US$808.9m
A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
GERN
US$1.27
7D
7.6%
1Y
-66.7%
Nuvation Bio
Market Cap: US$769.0m
A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.
NUVB
US$2.26
7D
8.1%
1Y
-31.9%